{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:55:13Z","timestamp":1790672113361,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00284-010-9699-x","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T06:29:31Z","timestamp":1278397771000},"page":"255-260","source":"Crossref","is-referenced-by-count":71,"title":["Efficacy of Polyvalent Bacteriophage P-27\/HP to Control Multidrug Resistant Staphylococcus aureus Associated with Human Infections"],"prefix":"10.1007","volume":"62","author":[{"given":"Ragini","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"9699_CR1","doi-asserted-by":"crossref","DOI":"10.5962\/bhl.title.6966","volume-title":"Bacteriophages","author":"MH Adams","year":"1959","unstructured":"Adams MH (1959) Bacteriophages. Interscience, New York"},{"issue":"1","key":"9699_CR2","first-page":"49","volume":"21","author":"S Anupurba","year":"2003","unstructured":"Anupurba S, Sen MR, Nath G et al (2003) Prevalence of methicillin resistance Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21(1):49\u201351","journal-title":"Indian J Med Microbiol"},{"key":"9699_CR3","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.01513-06","volume":"51","author":"R Capparelli","year":"2007","unstructured":"Capparelli R, Parlato M, Borriello G et al (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51:2765\u20132773. doi: 10.1128\/AAC.01513-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9699_CR4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0924-8579(07)72175-1","volume":"29","author":"AL Casey","year":"2007","unstructured":"Casey AL, Lambert PA, Elliott TSJ (2007) Staphylococci. Int J Antimicrob Agents 29(3):S23\u2013S32. doi: 10.1016\/S0924-8579(07)72175-1","journal-title":"Int J Antimicrob Agents"},{"key":"9699_CR5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJMe058023","volume":"352","author":"HF Chamber","year":"2005","unstructured":"Chamber HF (2005) Community-associated MRSA\u2014resistance and virulence converge. New Engl J Med 352:1485\u20131487","journal-title":"New Engl J Med"},{"key":"9699_CR6","volume-title":"Manual for identification of medical bacteria","author":"ST Cowan","year":"1975","unstructured":"Cowan ST, Steel KJ (1975) Manual for identification of medical bacteria. Cambridge University press, London"},{"issue":"2","key":"9699_CR7","first-page":"221","volume":"4","author":"J El-Jakee","year":"2008","unstructured":"El-Jakee J, Nagwa AS, Bakry M et al (2008) Characteristics of Staphylococcus aureus strains isolated from human and animal sources. Am Eurasian J Agric Environ Sci 4(2):221\u2013229","journal-title":"Am Eurasian J Agric Environ Sci"},{"key":"9699_CR8","first-page":"449","volume-title":"Methods in virology 1","author":"A Eisenstark","year":"1967","unstructured":"Eisenstark A (1967) Bacteriophage techniques. In: Maramorsch K, Koprowski H (eds) Methods in virology 1. Academic press, New York, pp 449\u2013524"},{"issue":"8","key":"9699_CR9","first-page":"766","volume":"10","author":"A Gorski","year":"2009","unstructured":"Gorski A, Miedzybrodzki R, Borysowski J et al (2009) Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs 10(8):766\u2013774","journal-title":"Curr Opin Investig Drugs"},{"key":"9699_CR10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-119-4-199308150-00010","volume":"119","author":"JA Jernigan","year":"1993","unstructured":"Jernigan JA, Farr BM (1993) Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 119:304\u2013311","journal-title":"Ann Intern Med"},{"key":"9699_CR11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI200318535","volume":"111","author":"FD Lowy","year":"2003","unstructured":"Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265\u20131273. doi: 10.1172\/JCI200318535","journal-title":"J Clin Invest"},{"key":"9699_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/374001","volume":"187","author":"S Matsuzaki","year":"2003","unstructured":"Matsuzaki S, Yasuda M, Nishikawa H et al (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 187:613\u2013624. doi: 10.1086\/374001","journal-title":"J Infect Dis"},{"key":"9699_CR13","doi-asserted-by":"crossref","unstructured":"Merabishvili M, Pirnay JP, Verbeken G et al (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4(3):e4944. doi: 10.1371\/journal.pone.0004944","DOI":"10.1371\/journal.pone.0004944"},{"key":"9699_CR14","volume-title":"Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A6","author":"National Committee for Clinical Laboratory Standards","year":"2000","unstructured":"National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A6, 7th edn. NCCLS, Wayne, PA","edition":"7"},{"key":"9699_CR15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/AEM.71.4.1836-1842.2005","volume":"71","author":"S O\u2019Flaherty","year":"2005","unstructured":"O\u2019Flaherty S, Ross RP, Meaney W et al (2005) Potential of the polyvalent anti-Staphylococcus bacteriophage K for the control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71:1836\u20131842. doi: 10.1128\/AEM.71.4.1836-1842.2005","journal-title":"Appl Environ Microbiol"},{"key":"9699_CR16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1574-6976.2009.00176.x","volume":"33","author":"S O\u2019Flaherty","year":"2009","unstructured":"O\u2019Flaherty S, Ross RP, Coffey A (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33:801\u2013819. doi: 10.1111\/j.1574-6976.2009.00176.x","journal-title":"FEMS Microbiol Rev"},{"key":"9699_CR17","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.303.5665.1798","volume":"303","author":"RF Service","year":"2004","unstructured":"Service RF (2004) Orphan drugs of the future? Science 303:1798. doi: 10.1126\/science.303.5665.1798","journal-title":"Science"},{"key":"9699_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649\u2013659. doi: 10.1128\/AAC.45.3.649-659.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"9699_CR19","doi-asserted-by":"crossref","unstructured":"Synnott AJ, Kuang Y, Kurimoto M et al (2009) Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl Environ Microbiol 4483\u20134490. doi: 10.1128\/AEM.02641-08","DOI":"10.1128\/AEM.02641-08"},{"key":"9699_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2007.04.003","volume":"30","author":"RP Wenzel","year":"2007","unstructured":"Wenzel RP, Bearman G, Edmond MB (2007) Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents 30:210\u2013212. doi: 10.1016\/j.ijantimicag.2007.04.003","journal-title":"Int J Antimicrob Agents"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-010-9699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-010-9699-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-010-9699-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:53:52Z","timestamp":1685660032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-010-9699-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["9699"],"URL":"https:\/\/doi.org\/10.1007\/s00284-010-9699-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}